BYSI
BYSI
NASDAQ · Biotechnology

Beyondspring Inc

$0.63
+0.03 (+4.16%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +6,928.8% upside
Low Target $29.80
Average Target $44.00
High Target $55.04
Current Price $0.63
Current
$0.63
Target
$44.00
$29.80 $44.00 avg $55.04
Scenario Analysis
Bear Case
$29.80
4,660.4%
Low target
Base Case
$44.00
+6,928.8%
Avg target
Bull Case
$55.04
+8,692.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.44
-74.3% from high
52-Week Low
$0.42
+48.5% from low
Target vs 52W High
$44.00
+1,703.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%